Welcome to LookChem.com Sign In|Join Free

CAS

  • or

4130-54-5

Post Buying Request

4130-54-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4130-54-5 Usage

General Description

Stearic acid hydrazide is a chemical compound that is derived from stearic acid, a saturated fatty acid found in animal and vegetable fats. It is commonly used as a precursor for the synthesis of other organic compounds and plays a role in the production of certain polymers and plastics. Stearic acid hydrazide is also utilized as a corrosion inhibitor in metalworking fluids and as a stabilizer in some cosmetic and personal care products. Additionally, it has been investigated for its potential antimicrobial and antioxidant properties, and its use in the pharmaceutical industry for drug delivery systems. Overall, stearic acid hydrazide has a variety of industrial and commercial applications due to its versatile chemical properties.

Check Digit Verification of cas no

The CAS Registry Mumber 4130-54-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,1,3 and 0 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 4130-54:
(6*4)+(5*1)+(4*3)+(3*0)+(2*5)+(1*4)=55
55 % 10 = 5
So 4130-54-5 is a valid CAS Registry Number.
InChI:InChI=1/C18H38N2O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(21)20-19/h2-17,19H2,1H3,(H,20,21)

4130-54-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A18291)  Stearic acid hydrazide, 97%   

  • 4130-54-5

  • 10g

  • 311.0CNY

  • Detail
  • Alfa Aesar

  • (A18291)  Stearic acid hydrazide, 97%   

  • 4130-54-5

  • 50g

  • 1107.0CNY

  • Detail
  • Alfa Aesar

  • (A18291)  Stearic acid hydrazide, 97%   

  • 4130-54-5

  • 250g

  • 4417.0CNY

  • Detail

4130-54-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name STEARIC ACID HYDRAZIDE

1.2 Other means of identification

Product number -
Other names Stearic Hydrazide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:4130-54-5 SDS

4130-54-5Relevant articles and documents

Newly synthesized oxadiazole based mannich base derivatives of fatty acid: In silico study and in vivo anti-hyperglycaemic estimation

Kapoor, Garima,Pathak, Dharam Pal,Bhutani, Rubina,Husain, Asif,Jain, Sandeep,Kant, Ravi,Iqbal, Md. Azhar

, p. 2253 - 2267 (2018)

A receptor peroxisome proliferator activated receptor-gamma was targeted by series of new fatty acid chemical entities (M1-M22) which was designed, synthesized and characterized by spectral analysis. Metabolites molecular properties were calculated using Lipinski’s rule of five using molinspiration online software. Docking studies were done on co-crystallized protein structure of PPAR γ, PDB-1FM9 showing M15, M17 and M8 to be best located in the active sites with scores -10.43, -10.21 and -10.00 respectively. The free binding energy estimation was done using model of Maestro 9.0 (Schrodinger) and lies between -80.15 to -61.26 kcal/mol which is significant as compared to that of standard (-48.58 Kcal/mol). Nine best docked derivatives were evaluated in-vivo for oral glucose tolerance and antihyperglycemic activity by streptozotocin induced diabetes model and M15 exhibited most promising antidiabetic activity more than the standard glibenclamide. The promising results encourage future investigation on fatty acids for development of active compounds.

Synthesis of 5-heptadecyl- and 5-heptadec-8-enyl substituted 4-amino-1,2,4-triazole-3-thiol and 1,3,4-oxadiazole-2-thione from (Z)-octadec-9-enoic acid: preparation of Palladium(II) complexes and evaluation of their antimicrobial activity

Chehrouri, Manel,Gholinejad, Mohammad,Moreno-Cabrerizo, Cristina,Othman, Adil A.,Sansano, José M.

, (2020/02/11)

Abstract: Two 4-amino-1,2,4-triazoles and two 1,3,4-oxadiazoles are obtained in a common synthetic route including hydrogenation-hydrazidation of (Z)-methyl octadec-9-enoate to octadecanoic hydrazide under atmospheric air. Preservation of olefinic bond in heptadec-8-enyl group is achieved by carrying out hydrazidation reaction under the presence of an argon atmosphere. The disappearance of the olefinic bond is detected by physical data, IR, 1H, and13C NMR spectroscopy. New palladium complexes derived from 4-amino-5-heptadecyl-1,2,4-triazole-3-thiol and 5-heptadecyl-1,3,4-oxadiazole-2(3H)-thione are obtained and characterized by elemental analysis (solid state), IR, 1H, 13C NMR spectroscopy, XRD, and XPS. These resulting metallic entities are also identified in solution based in mass spectrometry (MS-ESI) experiments. Most compounds and their palladium(II) complexes are tested in vitro against Gram-positive, Gram-negative bacteria, and fungi, some of them showed variable activity. Graphic abstract: [Figure not available: see fulltext.].

A new class of human fatty acid synthase inhibitors: Synthesis and their anticancer evaluation

Jubie,Bincy,Jameera Begam,Ashish,Kalirajan,Afzal Azam

, p. 671 - 678 (2019/05/22)

A series of 3-pentadecyl/heptadecyl-6-subsituted phenyl[l,2,4]triazolo[3,4-&][l,3,4]thiadiazoles have been designed, synthesized and screened for their in vitro antitumour activity against breast cancer cell Jines. Three compounds namely, 3- pentadecyl-6-phenyl[l,2,4]triazolo[3,4-b][l,3,4]thiadiazole (6e), 3-heptadecyl-6-phenyl[l,2,4]triazolo[3,4-i][l,3,4]thiadiazole (6j) and 3-heptadecyl-6(3-nitrophenyl)[l,2,4]triazolo[3,4b][l,3,4]-thiadiazole (6g) have displayed comparable activities towards human breast cancer lines. Molecular docking studies have been carried out on the crystal structure of human fatty acid synthase thioesterase domain (2PX6) by using GLIDE integrated Maestro 9.3 version. The designed compounds have shown good binding interactions with the active site residues present in the enzyme and have given very good G-scores when compared to the known inhibitor orlistat.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 4130-54-5